References
Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J (2009) Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 13:R105
Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB (2006) Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8:264–280
Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, Venkatesh B (2011) Continuation of statin therapy in patients with presumed infection: a randomised controlled trial. Am J Respir Crit Care Med 183:774–781
Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K (2008) Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Metabolism 57:1711–1718
van Hoek M, van Tol A, der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM (2009) Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes. Curr Med Res Opin 25:93–101
Khan T, Hamilton MP, Mundy DI, Chua SC, Scherer PE (2009) Impact of simvastatin on adipose tissue: pleiotropic effects in vivo. Endocrinology 150:5262–5272
Ohashi T, Shibata R, Morimoto T, Kanashiro M, Ishii H, Ichimiya S, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura T, Daida H, Murohara T, Matsuzaki M (2010) Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Atherosclerosis 212:237–242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robinson, K., Kruger, P., Phillips, L.K. et al. Effect of statin therapy on plasma adiponectin concentrations in patients with the sepsis syndrome: a preliminary investigation. Intensive Care Med 37, 1388–1389 (2011). https://doi.org/10.1007/s00134-011-2247-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-011-2247-8